Dual pH-sensitive nanodrug blocks PD-1 immune checkpoint and uses T cells to deliver NF-κB inhibitor for antitumor immunotherapy

A potent drug delivery strategy promotes tumor infiltration of T cells and unleashes antitumor immunity.